Global Blood and Urine Collection Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Blood Collection Devices, Urine Collection Devices), Application (Diagnostics, Therapeutics, Research & Development, Disease Screening), End User (Hospitals & Clinics, Diagnostic Laboratories, Blood Banks, Home Healthcare, Others) and Region Forecast 2020-2031

Blood and urine collection Market size was valued at US$ 9,647.3 million in 2024 and is projected to reach US$ 15,593.1 million by 2031 grew at 7.3% from 2025-2031. Moreover, the USA Blood and urine collection Market is projected to grow significantly, reaching an estimated value of US$ 3,873.1 Million by 2031. The market encompasses all products, tools, and solutions used for collecting and transporting blood and urine samples for clinical and laboratory analysis. This market includes vacuum blood collection systems, micro-collection devices, urine sample cups, transport bags, and associated accessories used across healthcare facilities, research laboratories, and home healthcare setups.

The market are marked by continuous growth as healthcare systems worldwide emphasize early diagnosis and disease prevention. The increasing burden of lifestyle diseases, coupled with the expansion of diagnostic laboratories and point-of-care testing services, fuels market demand. Innovations focused on improving sample integrity, minimizing contamination risks, and enhancing patient comfort are shaping product development. Furthermore, rising healthcare investments in emerging markets and the growing elderly population are expected to provide new growth opportunities for market players.

Key Players

The global market share is inclusive of several Blood and urine collection companies such as Grifols, Quest Diagnostics, Teleflex Incorporated, Hollister Incorporated, Amsino International Inc. Boston Scientific Corporation, Braun Melsungen AG, Medline Industries, Inc. Becton Dickinson and Company (BD), Wihuri Packaging Oy. Sarstedt AG Co.KG.

Key Developments

• In February 2024, Greiner Bio-One International GmbH introduced new sustainable packaging for its MiniCollect® Capillary Blood Collection System, supporting environmentally friendly practices while maintaining product safety and quality for diagnostic laboratories.
• In September 2023, Becton, Dickinson and Company (BD) launched its BD Vacutainer® UltraTouch™ Push Button Blood Collection Set, enhancing patient comfort and safety by integrating advanced needle technology and reducing needle-stick injuries for healthcare professionals.

Blood And Urine Collection Market Segmentation

Based on the Product type:

• Blood Collection Devices
• Urine Collection Devices

Based on product type, blood collection devices are anticipated to lead the market and hold the largest share. This dominance is primarily driven by the growing global demand for routine blood tests, which are essential for diagnosing a wide range of conditions, from chronic diseases such as diabetes and cardiovascular disorders to infectious diseases and cancer. Blood tests are considered a fundamental part of preventive healthcare, early detection, and treatment monitoring. The rise in lifestyle-related illnesses, coupled with an aging population requiring regular health assessments, further boosts demand for advanced blood collection products. Additionally, the growing preference for minimally invasive procedures and the increasing use of automated blood collection systems in hospitals and diagnostic labs contribute to this segment’s growth. Continuous innovation in safety-engineered blood collection devices, such as vacuum-based tubes and closed systems that minimize contamination risks, also strengthens market leadership. As healthcare infrastructures expand globally, blood collection devices remain indispensable to clinical diagnostics.

Based on the Application:

• Diagnostics
• Therapeutics
• Research & Development
• Disease Screening

Based on application, diagnostics is anticipated to lead the market, holding the largest share. The dominance of the diagnostics segment is driven by the increasing global demand for laboratory tests used in the detection, monitoring, and management of various diseases. Blood and urine samples are fundamental for diagnosing chronic conditions such as diabetes, cardiovascular diseases, kidney disorders, and infectious diseases. The growing burden of these conditions worldwide has accelerated the need for efficient diagnostic services. In addition, rising awareness about preventive healthcare and routine checkups has further increased the volume of diagnostic testing across hospitals, diagnostic labs, and outpatient clinics. The expanding elderly population, who require regular diagnostic evaluations, also plays a significant role in driving this segment. Moreover, advancements in laboratory technologies and automation have led to faster and more accurate test results, reinforcing the importance of blood and urine collection devices in diagnostics. This growing demand solidifies diagnostics as the leading application in the market.

Based on the end user:

• Hospitals & Clinics
• Diagnostic Laboratories
• Blood Banks
• Home Healthcare
• Others

Based on the end user, hospitals and clinics are anticipated to lead the market and hold the largest market share. This dominance is attributed to the high patient footfall, the constant need for diagnostic procedures, and the diverse range of healthcare services provided by hospitals and clinics. Blood and urine collection are routine processes in hospitals for diagnosing illnesses, monitoring patient conditions, and pre-surgical evaluations. The growing prevalence of chronic diseases, such as diabetes and hypertension, has resulted in a consistent increase in patient visits to healthcare facilities for regular monitoring, further driving demand. Additionally, emergency care and inpatient departments require frequent and reliable sample collection for rapid diagnostics. Hospitals also benefit from advanced laboratory setups that support automated blood collection systems and ensure accurate testing. As healthcare spending increases globally and hospital infrastructure continues to expand, the segment remains the largest end-user, driven by comprehensive patient care and continuous diagnostic requirements.